SCHEMBL6094870

SCHEMBL6094870

O=c1cc(-c2cccc(-c3cc(=O)c4c(O)cccc4o3)c2)oc2cccc(O)c12

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.85
MAPT P10636 4/20 0.85
AR P10275 12/20 0.84
MEN1 O00255 4/20 0.84
KMT2A Q03164 4/20 0.84
ALOX15 P16050 2/20 0.84
CYP1A1 P04798 2/20 0.84
CYP1A2 P05177 2/20 0.84
ALDH1A1 P00352 1/20 0.84
PKM P14618 1/20 0.84
SMN1; SMN2 Q16637 1/20 0.84
CYP1B1 Q16678 1/20 0.84
FTO Q9C0B1 1/20 0.84
MAPK1 P28482 2/20 0.79
POLH Q9Y253 2/20 0.79
KDM4E B2RXH2 1/20 0.79
ALOX5 P09917 1/20 0.79
CYP2C9 P11712 1/20 0.79
ALOX12 P18054 1/20 0.79
CYP2C19 P33261 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649971 0.92 CYP3A4 (1.00) CYP3A4MAPTARMEN1KMT2A
5-Hydroxyflavone SCHEMBL2390993 0.92 AR (1.00) CYP3A4MAPTARMEN1KMT2A
5-Hydroxyflavone SCHEMBL30630415 0.92 AR (1.00) CYP3A4MAPTARMEN1KMT2A
5-Hydroxyflavone SCHEMBL158303 0.92 AR (1.00) CYP3A4MAPTARMEN1KMT2A
5-Hydroxyflavone SCHEMBL2390943 0.90 AR (0.97) CYP3A4MAPTARMEN1KMT2A
5-Hydroxyflavone SCHEMBL28317755 0.90 AR (0.97) CYP3A4MAPTARMEN1KMT2A
SCHEMBL3817277 0.89 CYP3A4 (1.00) CYP3A4MAPTARMEN1KMT2A
SCHEMBL30591245 0.89 CYP3A4 (1.00) CYP3A4MAPTARMEN1KMT2A
SCHEMBL157490 0.87 AR (1.00) CYP3A4MAPTARMEN1KMT2A
SCHEMBL3817662 0.87 CYP3A4 (0.75) CYP3A4MAPTARMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7009062-B2 Process for the preparation of flavone derivatives MERCK PATENT GMBH (DE) 2006-03-07 US disclosed
EP-1355898-B1 METHOD FOR PRODUCING FLAVONE DERIVATIVES MERCK PATENT GMBH (DE) 2005-10-12 EP disclosed
US-20040059100-A1 Process for the preparation of flavone derivatives EUROPEAN BRAND PARTICIPATIONS SA (LU) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059100-A1 Process for the preparation of flavone derivatives HK2, MAP2K5, MAP2K4 CYP3A4 38/4885MAPT 842/4885AR 2913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.